These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 24998573)
41. Overexpression of annexin A4 indicates poor prognosis and promotes tumor metastasis of hepatocellular carcinoma. Chen W; Chen L; Cai Z; Liang D; Zhao B; Zeng Y; Liu X; Liu J Tumour Biol; 2016 Jul; 37(7):9343-55. PubMed ID: 26779633 [TBL] [Abstract][Full Text] [Related]
42. Anti-invasion and anti-migration effects of miR-199a-3p in hepatocellular carcinoma are due in part to targeting CD151. Kim JH; Badawi M; Park JK; Jiang J; Mo X; Roberts LR; Schmittgen TD Int J Oncol; 2016 Nov; 49(5):2037-2045. PubMed ID: 27599545 [TBL] [Abstract][Full Text] [Related]
43. MicroRNA-608 acts as a prognostic marker and inhibits the cell proliferation in hepatocellular carcinoma by macrophage migration inhibitory factor. Wang K; Liang Q; Wei L; Zhang W; Zhu P Tumour Biol; 2016 Mar; 37(3):3823-30. PubMed ID: 26474589 [TBL] [Abstract][Full Text] [Related]
44. MiR-335 acts as a potential tumor suppressor miRNA via downregulating ROCK1 expression in hepatocellular carcinoma. Liu H; Li W; Chen C; Pei Y; Long X Tumour Biol; 2015 Aug; 36(8):6313-9. PubMed ID: 25804796 [TBL] [Abstract][Full Text] [Related]
45. RASSF10 is an epigenetically inactivated tumor suppressor and independent prognostic factor in hepatocellular carcinoma. Wang F; Feng Y; Li P; Wang K; Feng L; Liu YF; Huang H; Guo YB; Mao QS; Xue WJ Oncotarget; 2016 Jan; 7(4):4279-97. PubMed ID: 26701853 [TBL] [Abstract][Full Text] [Related]
46. MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma. Fang F; Chang RM; Yu L; Lei X; Xiao S; Yang H; Yang LY J Hepatol; 2015 Oct; 63(4):874-85. PubMed ID: 25998163 [TBL] [Abstract][Full Text] [Related]
47. miR-383 inhibits hepatocellular carcinoma cell proliferation via targeting APRIL. Chen L; Guan H; Gu C; Cao Y; Shao J; Wang F Tumour Biol; 2016 Feb; 37(2):2497-507. PubMed ID: 26385772 [TBL] [Abstract][Full Text] [Related]
48. MicroRNA-105 suppresses cell proliferation and inhibits PI3K/AKT signaling in human hepatocellular carcinoma. Shen G; Rong X; Zhao J; Yang X; Li H; Jiang H; Zhou Q; Ji T; Huang S; Zhang J; Jia H Carcinogenesis; 2014 Dec; 35(12):2748-55. PubMed ID: 25280563 [TBL] [Abstract][Full Text] [Related]
49. Evaluation of MiR-34 Family and DNA Methyltransferases 1, 3A, 3B Gene Expression Levels in Hepatocellular Carcinoma Following Treatment with Dendrosomal Nanocurcumin. Chamani F; Sadeghizadeh M; Masoumi M; Babashah S Asian Pac J Cancer Prev; 2016; 17(S3):219-24. PubMed ID: 27165229 [TBL] [Abstract][Full Text] [Related]
50. Differential expression of IQGAP1/2 in Hepatocellular carcinoma and its relationship with clinical outcomes. Xia FD; Wang ZL; Chen HX; Huang Y; Li JD; Wang ZM; Li XY Asian Pac J Cancer Prev; 2014; 15(12):4951-6. PubMed ID: 24998570 [TBL] [Abstract][Full Text] [Related]
51. Chromobox homolog 4 is correlated with prognosis and tumor cell growth in hepatocellular carcinoma. Wang B; Tang J; Liao D; Wang G; Zhang M; Sang Y; Cao J; Wu Y; Zhang R; Li S; Ding W; Zhang G; Kang T Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S684-92. PubMed ID: 23943028 [TBL] [Abstract][Full Text] [Related]
52. MiR-490-5p Inhibits Hepatocellular Carcinoma Cell Proliferation, Migration and Invasion by Directly Regulating ROBO1. Chen W; Ye L; Wen D; Chen F Pathol Oncol Res; 2019 Jan; 25(1):1-9. PubMed ID: 28924964 [TBL] [Abstract][Full Text] [Related]
53. Increased expression of miR-21 predicts poor prognosis in patients with hepatocellular carcinoma. Huang CS; Yu W; Cui H; Wang YJ; Zhang L; Han F; Huang T Int J Clin Exp Pathol; 2015; 8(6):7234-8. PubMed ID: 26261620 [TBL] [Abstract][Full Text] [Related]
54. Prognostic significance and anti-proliferation effect of microRNA-365 in hepatocellular carcinoma. Chen Z; Huang Z; Ye Q; Ming Y; Zhang S; Zhao Y; Liu L; Wang Q; Cheng K Int J Clin Exp Pathol; 2015; 8(2):1705-11. PubMed ID: 25973057 [TBL] [Abstract][Full Text] [Related]
55. Decreased expression and clinical significance of miR-148a in hepatocellular carcinoma tissues. Pan L; Huang S; He R; Rong M; Dang Y; Chen G Eur J Med Res; 2014 Dec; 19(1):68. PubMed ID: 25444499 [TBL] [Abstract][Full Text] [Related]
56. [The expression and clinopathological significance of miR-130b in human hepatocellular carcinoma]. Xu Q; Cai W; Zhang M; Liu Q; Liu X Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Mar; 32(3):387-92. PubMed ID: 26927562 [TBL] [Abstract][Full Text] [Related]
57. Regulation of tumorigenesis and metastasis of hepatocellular carcinoma tumor endothelial cells by microRNA-3178 and underlying mechanism. Li W; Shen S; Wu S; Chen Z; Hu C; Yan R Biochem Biophys Res Commun; 2015 Aug; 464(3):881-7. PubMed ID: 26182877 [TBL] [Abstract][Full Text] [Related]
58. Decreased microRNA-452 expression and its prognostic significance in human osteosarcoma. Li RZ; Wang LM World J Surg Oncol; 2016 May; 14():150. PubMed ID: 27193084 [TBL] [Abstract][Full Text] [Related]
59. Extracellular HSP70-peptide complexes promote the proliferation of hepatocellular carcinoma cells via TLR2/4/JNK1/2MAPK pathway. Zhe Y; Li Y; Liu D; Su DM; Liu JG; Li HY Tumour Biol; 2016 Oct; 37(10):13951-13959. PubMed ID: 27492456 [TBL] [Abstract][Full Text] [Related]
60. Exosomal MiR-744 Inhibits Proliferation and Sorafenib Chemoresistance in Hepatocellular Carcinoma by Targeting PAX2. Wang G; Zhao W; Wang H; Qiu G; Jiang Z; Wei G; Li X Med Sci Monit; 2019 Sep; 25():7209-7217. PubMed ID: 31553714 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]